Preliminary indications signifying the role of ATP13A2 in sporadic PD came from the observation that ATP13A2 mRNA levels increase in surviving dopaminergic SN neurons from brains of patients with sporadic PD [215]. The gene discussed is ATP13A2; the disease is Parkinson disease.